Establishment of the Breast Milk Database in China

July 29, 2019 updated by: Heilongjiang Feihe Dairy Co. Ltd.
Collect breast milk samples in various administrative regions of China to measure the nutrients in breast milk; analyze the composition of nutrients; and establish the database of breast milk in China.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The study cities are Guangzhou, Weihai, Chengdu, Beijing, Harbin, Wuhan, Jinhua, Zhengzhou and Lanzhou.

Breast milk will be collected at 9:00-11:00 in the morning from 15 to180 days after giving birth. The nutrients (protein, triglyceride, phospholipid, oligosaccharides and probiotics) in the collected breast milk samples will be measured. These data will be used to establish the breast milk database in China. This databased will provide references for infant nutrient intake and for the formulation and revision of infant formula standards. It will also provide references for the development of new infant formula products in China.

Study Type

Observational

Enrollment (Actual)

1800

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Healthy lactating mother of 25 ~ 35 years old who are currently breast-feeding infants of 15 ~180 days old. Subjects are equally distributed in the postpartum time period of 15~35 days, 36~65 days, 66~95 days, 96~125 days, 126~55 days and 156~185 days

Description

Inclusion Criteria:

  • Lactating mother 25 ~ 35 years old;
  • Breast-feeding infants (15 ~180 days old );
  • Physically healthy by self-evaluation;
  • Does not smoke;
  • Does not drink alcohol;
  • Have given birth to physically healthy infants;
  • Signed the informed consent forms.

Exclusion Criteria:

  • Being treated for gastrointestinal symptoms;
  • Suffering from mastitis;
  • Suffering from infectious diseases (tuberculosis, viral hepatitis and HIV infection);
  • Suffering from cardiovascular disease;
  • Suffering from metabolic diseases (such as diabetes);
  • Suffering from mental system diseases;
  • Suffering from cancer and other malignant diseases;
  • Having history of taking antibiotics;
  • Not able to answer the study questions;
  • Participating in any nutritional or pharmaceutical intervention study recently.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Other

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Protein in breast milk
Time Frame: At enrollment
Protein in breast milk measured in percent (%)
At enrollment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Osmotic pressure
Time Frame: At enrollment
Osmotic pressure (mmolOsm/Lkg.H2O) in breast milk
At enrollment
Fatty acids in breast milk
Time Frame: At enrollment
Fatty acids composition (mg/L) in breast milk
At enrollment
Amino acids
Time Frame: At enrollment
Amino acids composition (mg/L) in breast milk
At enrollment
Oligosaccharides
Time Frame: At enrollment
Oligosaccharides levels (mg/L) in breast milk
At enrollment
Probiotics
Time Frame: At enrollment
Probiotics composition (species) measured using gene sequencing in breast milk;
At enrollment
Vitamins
Time Frame: At enrollment
Vitamins composition (μg/L) in breast milk
At enrollment
Minerals
Time Frame: At enrollment
Minerals composition (mg/L) in breast milk
At enrollment
Hormones
Time Frame: At enrollment
Hormones composition (mg/L) in breast milk
At enrollment
Dietary composition of participating mothers
Time Frame: At enrollment
Investigation on the dietary composition of participating mothers obtained using questionnaire
At enrollment
Height of participating mothers
Time Frame: At enrollment
Height measurement (cm) of participating mothers
At enrollment
Weight of participating mothers
Time Frame: At enrollment
Body weight measurement (kg) of participating mothers
At enrollment
Age of participating mothers
Time Frame: At enrollment
Age (years) of participating mothers obtained using questionnaire
At enrollment
Educational level of participating mothers
Time Frame: At enrollment
Educational level of participating mothers obtained using questionnaire
At enrollment
Occupation of participating mothers
Time Frame: At enrollment
Occupation of participating mothers obtained using questionnaire
At enrollment
Physical health condition of participating mothers
Time Frame: At enrollment
Physical health condition of participating mothers assessed by questionnaire
At enrollment
Triglyceride
Time Frame: At enrollment
Triglyceride (mg/g) contents in breast milk
At enrollment
Phospholipid
Time Frame: At enrollment
Phospholipid (mg/g) contents in breast milk
At enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Shilong Jiang, Heilongjiang Feihe Dairy Co. Ltd.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 19, 2016

Primary Completion (Actual)

August 1, 2018

Study Completion (Actual)

December 30, 2018

Study Registration Dates

First Submitted

September 5, 2018

First Submitted That Met QC Criteria

September 16, 2018

First Posted (Actual)

September 18, 2018

Study Record Updates

Last Update Posted (Actual)

July 31, 2019

Last Update Submitted That Met QC Criteria

July 29, 2019

Last Verified

September 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 16-SC-05-FC-001

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Milk Collection

Clinical Trials on No intervention

Subscribe